Cellectis Reports Financial Results for Third Quarter and First Nine Months 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Cellectis (CLLS) Tops Q3 EPS by 26c
November 6, 2019 5:23 PM ESTCellectis (NASDAQ: CLLS) reported Q3 EPS of ($0.54), $0.26 better than the analyst estimate of ($0.80). Revenue for the quarter came in at $2.19 million versus the consensus estimate of $3.28 million.
The third quarter of 2019 has been essential for our execution strategy, as we achieved a series of important key... More
